Conversely, NFTs found in the brains of AD patients and hyperphosphorylated tau inclusions from mutant tau transgenic mouse brains were both negative for SUMO1 immunoreactivity (Takahashi et al., 2008). Here, MAPT is linked to Alzheimer disease.